Welcome to the NIH Collaboratory E-Newsletter! The newsletter is intended to provide a convenient monthly wrap-up of NIH Collaboratory news, along with featured stories and a look at what’s coming in the month ahead. We hope you’ll find it useful, and we’d love to hear your feedback.
Please let us know what you think.
|
|
|
Recent News
Reflections From the Patient-Reported Outcomes Core: Dr. Kevin Weinfurt, chair of the Patient-Reported Outcomes (PRO) Core, shares the successes of the first 5 years of the Core and looks ahead to the coming years: “We need to determine when PROs are essential, supporting, or not at all informative for the clinical questions. This gets at the value proposition: When are they of value and to whom?”
Implementation of Revised Common Rule Delayed: Federal departments and agencies announced a delay in the effective and compliance dates for the revised Common Rule. The delay will give institutions additional time to prepare to implement the revisions.
|
|
Podcasts
Don't miss our latest Grand Rounds podcast:
In this episode, Drs. Richard Platt and Christopher Granger speak with moderator Dr. Adrian Hernandez about the IMPACT-AFib trial. Researchers used pharmacy data from the FDA’s Sentinel Initiative to identify more than 80,000 potential participants.
Other recent Grand Rounds podcasts:
|
|
|
What is a Pragmatic Trial? Dr. Greg Simon uses props to explain pragmatic trials and their importance in clinical research. “Doctors, nurses, and other health care providers face lots of decisions. Pragmatic clinical trials are about helping doctors make better decisions to take care of their patients.”
|
|
The goal of the
TSOS trial, an NIH Collaboratory Demonstration Project, is to coordinate care and improve outcomes of trauma survivors with posttraumatic stress disorder (PTSD) at two dozen level 1 trauma centers in the United States. Because evidence-based treatments for patients with PTSD have not been broadly implemented in US trauma care systems, the TSOS trial also aims to provide evidence to inform regulatory policy.
In a recent interview, principal investigator Dr. Doug Zatzick discussed the status of the trial, challenges and surprises, and advice for new investigators. Download a
study snapshot about this trial.
|
|
Featured Publications & Products
|
|
|
|
|
|
|